Company Filing History:
Years Active: 2015-2022
Title: Zhan Xiao: Innovator in HER3 Targeting Therapies
Introduction
Zhan Xiao is a prominent inventor based in Boyds, MD (US), known for his significant contributions to the field of biotechnology. He holds 4 patents that focus on innovative therapies targeting the HER3 receptor, which plays a crucial role in various diseases.
Latest Patents
Zhan Xiao's latest patents include groundbreaking work on binding molecules specific for HER3 and their uses. These patents describe antibodies and antigen binding fragments that bind to the extracellular domain of the HER3 receptor. They inhibit various HER3 receptor-related functions through both ligand-dependent and ligand-independent mechanisms. Additionally, the patents provide compositions with increased half-life, as well as methods for diagnosing and treating diseases associated with HER3-mediated signal transduction.
Career Highlights
Throughout his career, Zhan Xiao has worked with notable companies such as MedImmune Limited. His work has significantly advanced the understanding and treatment of diseases linked to HER3 signaling pathways.
Collaborations
Zhan has collaborated with esteemed colleagues, including Partha S Chowdhury and David Tice, contributing to the development of innovative therapeutic solutions.
Conclusion
Zhan Xiao's work in developing HER3-targeting therapies showcases his dedication to advancing medical science. His patents and collaborations reflect his commitment to improving patient outcomes through innovative research.